Hadox Research Labs · Science Intelligence
We watch the research landscape, compare papers with fair peers, read the full text and publish the receipts. No journal logo, citation count or model gets the last word alone.
Current truthThe ascendance engine is still building history. This edition is editorially selected, not algorithmically declared “rising.”
Comparison universe1,138 current candidates across 41 age, field and article-type cohorts.
Evidence gateEvery public dossier was read from an authorised full body. Abstract-only records remain ineligible.
As of25 Jul 2026
This public, sanitized index unites the observatory with Hadox's reviewed dossiers. Bibliographic metadata and measured signal states are visible; abstracts and source text are not.
Tracking is not endorsement. A row means Hadox is monitoring the paper or has completed a public dossier. Radar states appear only when measured against age-, field- and article-type peers; no metric is invented for editorial selections.
Read the selection method| Paper | Field | Radar state | Attention | Next review | Hadox |
|---|---|---|---|---|---|
| Scheduled birth at term: benefit or trade-off? The Lancet · 2026-04-01 · 10.1016/s0140-6736(26)00312-0 | Epidemiology Research article | Baseline Candidate · 1 signal point | 0 citations Cohort 25% · 12 peers · signal 2026-07-21 | 2026-08-04 assessed 2026-07-21 | Tracking Not yet a public dossier |
| Semaglutide, weight loss, and cardiovascular outcomes in the SELECT trial The Lancet · 2026-04-01 · 10.1016/s0140-6736(26)00256-4 | Endocrinology, Diabetes and Metabolism Research article | Baseline Candidate · 1 signal point | 1 citations Cohort 63% · 8 peers · signal 2026-07-21 | 2026-08-04 assessed 2026-07-21 | Tracking Not yet a public dossier |
| Senescence in cancer: Hallmarks, paradoxes, and therapeutic promise Cell · 2026-04-01 · 10.1016/j.cell.2026.03.005 | Physiology Research article | Baseline Candidate · 1 signal point | 4 citations Cohort 58% · 12 peers · signal 2026-07-21 | 2026-08-04 assessed 2026-07-21 | Tracking Not yet a public dossier |
| Still dancing in defiance The Lancet · 2026-04-01 · 10.1016/s0140-6736(26)00614-8 | Psychology Research article | Baseline Candidate · 1 signal point | 0 citations Cohort 44% · 8 peers · signal 2026-07-21 | 2026-08-04 assessed 2026-07-21 | Tracking Not yet a public dossier |
| Structural erosion of epidemiology and Japan's next generation The Lancet · 2026-04-01 · 10.1016/s0140-6736(26)00644-6 | Sociology and Political Science Research article | Baseline Candidate · 1 signal point | 0 citations Cohort 27% · 13 peers · signal 2026-07-21 | 2026-08-04 assessed 2026-07-21 | Tracking Not yet a public dossier |
| Tackling the complexity of cancer with generative models Cell · 2026-04-01 · 10.1016/j.cell.2026.03.027 | Cancer Research Research article | Baseline Candidate · 1 signal point | 1 citations Cohort 10% · 5 peers · signal 2026-07-21 | 2026-08-04 assessed 2026-07-21 | Tracking Not yet a public dossier |
| Targeting angiogenesis: Lessons from 25 years of normalizing tumor vasculature Cell · 2026-04-01 · 10.1016/j.cell.2026.03.016 | Molecular Biology Research article | Baseline Candidate · 1 signal point | 5 citations Cohort 78% · 67 peers · signal 2026-07-21 | 2026-08-04 assessed 2026-07-21 | Tracking Not yet a public dossier |
| Targeting genomic instability in cancer Cell · 2026-04-01 · 10.1016/j.cell.2026.03.035 | Cell Biology Research article | Baseline Candidate · 1 signal point | 3 citations Cohort 85% · 10 peers · signal 2026-07-21 | 2026-08-04 assessed 2026-07-21 | Tracking Not yet a public dossier |
| Targeting MEK in cancer and beyond: mechanistic insights and therapeutic opportunities The Lancet · 2026-04-01 · 10.1016/s0140-6736(26)00199-6 | Molecular Biology Research article | Baseline Candidate · 1 signal point | 1 citations Cohort 40% · 67 peers · signal 2026-07-21 | 2026-08-04 assessed 2026-07-21 | Tracking Not yet a public dossier |
| The BMP Inhibitor Coco Reactivates Breast Cancer Cells at Lung Metastatic Sites Cell · 2026-04-01 · 10.1016/j.cell.2026.03.026 | Molecular Biology Research article | Baseline Candidate · 1 signal point | 0 citations Cohort 16% · 67 peers · signal 2026-07-21 | 2026-08-04 assessed 2026-07-21 | Tracking Not yet a public dossier |
| The future of preconception health The Lancet · 2026-04-01 · 10.1016/s0140-6736(26)00707-5 | Pediatrics, Perinatology and Child Health Research article | Baseline Candidate · 1 signal point | 0 citations Cohort 43% · 7 peers · signal 2026-07-21 | 2026-08-04 assessed 2026-07-21 | Tracking Not yet a public dossier |
| The Hallmarks of Cancer: 25 years guiding discovery and therapy Cell · 2026-04-01 · 10.1016/j.cell.2026.03.033 | Oncology Research article | Baseline Candidate · 1 signal point | 0 citations Cohort 26% · 19 peers · signal 2026-07-21 | 2026-08-04 assessed 2026-07-21 | Tracking Not yet a public dossier |
| The permission gap and moral velocity The Lancet · 2026-04-01 · 10.1016/s0140-6736(26)00593-3 | Cognitive Neuroscience Research article | Baseline Candidate · 1 signal point | 0 citations Cohort 30% · 5 peers · signal 2026-07-21 | 2026-08-04 assessed 2026-07-21 | Tracking Not yet a public dossier |
| The public health response to the Epstein files The Lancet · 2026-04-01 · 10.1016/s0140-6736(26)00545-3 | General Health Professions Research article | Baseline Candidate · 1 signal point | 0 citations Cohort 36% · 18 peers · signal 2026-07-21 | 2026-08-04 assessed 2026-07-21 | Tracking Not yet a public dossier |
| The US CDC on the brink The Lancet · 2026-04-01 · 10.1016/s0140-6736(26)00799-3 | Infectious Diseases Research article | Baseline Candidate · 1 signal point | 0 citations Cohort 25% · 16 peers · signal 2026-07-21 | 2026-08-04 assessed 2026-07-21 | Tracking Not yet a public dossier |
These are the exact visual editions already shared by Hadox. Each one now has a canonical source, immutable assets and a visible workflow state; publication history never substitutes for scientific review.
01
The source is identified, but no authorised full body is available for Hadox review yet.
02
Published edition linked to a full-text Hadox evidence dossier.
03
This official-source story is awaiting the institutional evidence workflow.
Historical copy retained; correction logged in the workflow.
Today, 0 papers have enough history for a momentum score and 0 public dossiers were selected by an open ascendance gate. That is not a failure to hide; it is the calibration state.
current paper assessments from Crossref + Openalex
cohorts split by paper age, article type and discipline
baseline · 1 watch · 0 rising
01Observe attention against fair peers.
02Wait for enough history to measure velocity.
03Read the authorised full paper and map every claim.
04Make a separate editorial decision and publish the evidence.